Sfoglia per Autore
Endothelial-to-Mesenchymal Transition in Bone Marrow and Spleen of Primary Myelofibrosis
2017 Erba, Benedetta Gaia; Gruppi, Cristian; Corada, Monica; Pisati, Federica; Rosti, Vittorio; Bartalucci, Niccoloâ ; Villeval, Jean-Luc; Vannucchi, Alessandro Maria; Barosi, Giovanni; Balduini, Alessandra; Dejana, Elisabetta
Role of TGF-β1/miR-382-5p/SOD2 axis in the induction of oxidative stress in CD34+ cells from primary myelofibrosis
2018 Rossi C.; Zini R.; Rontauroli S.; Ruberti S.; Prudente Z.; Barbieri G.; Bianchi E.; Salati S.; Genovese E.; Bartalucci N.; Guglielmelli P.; Tagliafico E.; Rosti V.; Barosi G.; Vannucchi A.M.; Manfredini R.
GIPSS: genetically inspired prognostic scoring system for primary myelofibrosis
2018 Tefferi, Ayalew; Guglielmelli, Paola; Nicolosi, Maura; Mannelli, Francesco; Mudireddy, Mythri; Bartalucci, Niccolo; Finke, Christy M; Lasho, Terra L; Hanson, Curtis A; Ketterling, Rhett P; Begna, Kebede H; Naseema Gangat, null; Pardanani, Animesh; Vannucchi, Alessandro M
Mutation landscape in patients with myelofibrosis receiving ruxolitinib or hydroxyurea
2018 Pacilli A.; Rotunno G.; Mannarelli C.; Fanelli T.; Pancrazzi A.; Contini E.; Mannelli F.; Gesullo F.; Bartalucci N.; Fattori G.C.; Paoli C.; Vannucchi A.M.; Guglielmelli P.
Involvement of RUNX1 Pathway Is a Common Event in the Leukemic Transformation of Chronic Myeloproliferative Neoplasms (MPNs)
2019 Paola Guglielmelli, MD PhD, Niccolò Bartalucci, PhDBSc, Elisa Contini, PhD, Giada Rotunno, PhD, Annalisa Pacilli, PhD, Simone Romagnoli, BSc, Lara Mannelli, MD, Francesco Mannelli, MD, Giacomo Coltro, MD, Alessandro Pancrazzi, PhD, Valentina Ariu, BSci, Sara Fiaccabrino, Roberto Semeraro, Alberto Magi, PhD, Carmela Mannarelli, PhD, Francesca Gesullo, BSci, Chiara Paoli, PhD, Alessandro M. Vannucchi, MD
NANOR: A user-friendly R package to analyze and compare nanopore sequencing data
2019 Bolognini D.; Bartalucci N.; Mingrino A.; Vannucchi A.M.; Magi A.
Calreticulin Ins5 and Del52 mutations impair unfolded protein and oxidative stress responses in K562 cells expressing CALR mutants
2019 Salati S.; Genovese E.; Carretta C.; Zini R.; Bartalucci N.; Prudente Z.; Pennucci V.; Ruberti S.; Rossi C.; Rontauroli S.; Enzo E.; Calabresi L.; Balliu M.; Mannarelli C.; Bianchi E.; Guglielmelli P.; Tagliafico E.; Vannucchi A.M.; Manfredini R.
Nano-GLADIATOR: real-time detection of copy number alterations from nanopore sequencing data
2019 Magi, Alberto; Bolognini, Davide; Bartalucci, Niccoló; Mingrino, Alessandra; Semeraro, Roberto; Giovannini, Luna; Bonifacio, Stefania; Parrini, Daniela; Pelo, Elisabetta; Mannelli, Francesco; Guglielmelli, Paola; Vannucchi, Alessandro Maria
Long Reads, Short Time: Feasibility of Prenatal Sample Karyotyping by Nanopore Genome Sequencing
2019 Bartalucci, Niccolò; Romagnoli, Simone; Contini, Elisa; Marseglia, Giuseppina; Magi, Alberto; Guglielmelli, Paola; Pelo, Elisabetta; Vannucchi, Alessandro M
THIRD GENERATION SEQUENCING OF NORMAL KARYOTYPE ACUTE MYELOID LEUKEMIA: IMPLICATIONS FOR PROGNOSIS
2019 Bartalucci, N; Mannelli, F; Contini, E; Romagnoli, S; Gianfaldoni, G; Scappini, B; Pelo, E; Pancani, F; Magi, A; Bosi, A; Guglielmelli, P; Vannucchi, AM
Characteristics and clinical correlates of NFE2 mutations in chronic Myeloproliferative neoplasms
2020 Guglielmelli P.; Pacilli A.; Coltro G.; Mannelli F.; Mannelli L.; Contini E.; Rotunno G.; Bartalucci N.; Fiaccabrino S.; Sordi B.; Loscocco G.G.; Paoli C.; Vannucchi A.M.
Polycythemia vera: the current status of preclinical models and therapeutic targets
2020 Bartalucci N.; Guglielmelli P.; Vannucchi A.M.
RAS/CBL mutations predict resistance to JAK inhibitors in myelofibrosis and are associated with poor prognostic features
2020 Coltro G.; Rotunno G.; Mannelli L.; Mannarelli C.; Fiaccabrino S.; Romagnoli S.; Bartalucci N.; Ravenda E.; Gelli E.; Sant'Antonio E.; Patnaik M.M.; Tefferi A.; Vannucchi A.M.; Guglielmelli P.
Activated IL-6 signaling contributes to the pathogenesis of, and is a novel therapeutic target for, CALR-mutated MPNs
2021 Balliu M.; Calabresi L.; Bartalucci N.; Romagnoli S.; Maggi L.; Manfredini R.; Lulli M.; Guglielmelli P.; Vannucchi A.M.
A blood drop through the pore: nanopore sequencing in hematology
2021 Bartalucci N.; Romagnoli S.; Vannucchi A.M.
Peripheral nerve resident macrophages and schwann cells mediate cancer-induced pain A C
2021 de Logu F.; Marini M.; Landini L.; de Araujo D.S.M.; Bartalucci N.; Trevisan G.; Bruno G.; Marangoni M.; Schmidt B.L.; Bunnett N.W.; Geppetti P.; Nassini R.
Philadelphia-negative myeloproliferative neoplasms: From origins to new perspectives
2021 Bartalucci, Niccolò; Galluzzi, Lorenzo
Nanopore sequencing for the screening of myeloid and lymphoid neoplasms with eosinophilia and rearrangement of PDGFRα, PDGFRβ, FGFR1 or PCM1-JAK2
2021 Romagnoli S.; Bartalucci N.; Gesullo F.; Balliu M.; Bonifacio S.; Fernandez A.G.L.; Mannelli F.; Bolognini D.; Pelo E.; Mecucci C.; Guglielmelli P.; Vannucchi A.M.
Immunoblotting-assisted assessment of JAK/STAT and PI3K/Akt/mTOR signaling in myeloproliferative neoplasms CD34+ stem cells
2022 Calabresi, Laura; Balliu, Manjola; Bartalucci, Niccolò
The Response to Oxidative Damage Correlates with Driver Mutations and Clinical Outcome in Patients with Myelofibrosis
2022 Genovese, Elena; Mirabile, Margherita; Rontauroli, Sebastiano; Sartini, Stefano; Fantini, Sebastian; Tavernari, Lara; Maccaferri, Monica; Guglielmelli, Paola; Bianchi, Elisa; Parenti, Sandra; Carretta, Chiara; Mallia, Selene; Castellano, Sara; Colasante, Corrado; Balliu, Manjola; Bartalucci, Niccolò; Palmieri, Raffaele; Ottone, Tiziana; Mora, Barbara; Potenza, Leonardo; Passamonti, Francesco; Voso, Maria Teresa; Luppi, Mario; Vannucchi, Alessandro Maria; Tagliafico, Enrico; Manfredini, Rossella; On Behalf Of The Mynerva MYeloid NEoplasms Research Venture Airc, null
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Endothelial-to-Mesenchymal Transition in Bone Marrow and Spleen of Primary Myelofibrosis | 2017 | Erba, Benedetta Gaia; Gruppi, Cristian; Corada, Monica; Pisati, Federica; Rosti, Vittorio; Bartalucci, Niccoloâ ; Villeval, Jean-Luc; Vannucchi, Alessandro Maria; Barosi, Giovanni; Balduini, Alessandra; Dejana, Elisabetta | |
Role of TGF-β1/miR-382-5p/SOD2 axis in the induction of oxidative stress in CD34+ cells from primary myelofibrosis | 2018 | Rossi C.; Zini R.; Rontauroli S.; Ruberti S.; Prudente Z.; Barbieri G.; Bianchi E.; Salati S.; Genovese E.; Bartalucci N.; Guglielmelli P.; Tagliafico E.; Rosti V.; Barosi G.; Vannucchi A.M.; Manfredini R. | |
GIPSS: genetically inspired prognostic scoring system for primary myelofibrosis | 2018 | Tefferi, Ayalew; Guglielmelli, Paola; Nicolosi, Maura; Mannelli, Francesco; Mudireddy, Mythri; Bartalucci, Niccolo; Finke, Christy M; Lasho, Terra L; Hanson, Curtis A; Ketterling, Rhett P; Begna, Kebede H; Naseema Gangat, null; Pardanani, Animesh; Vannucchi, Alessandro M | |
Mutation landscape in patients with myelofibrosis receiving ruxolitinib or hydroxyurea | 2018 | Pacilli A.; Rotunno G.; Mannarelli C.; Fanelli T.; Pancrazzi A.; Contini E.; Mannelli F.; Gesullo F.; Bartalucci N.; Fattori G.C.; Paoli C.; Vannucchi A.M.; Guglielmelli P. | |
Involvement of RUNX1 Pathway Is a Common Event in the Leukemic Transformation of Chronic Myeloproliferative Neoplasms (MPNs) | 2019 | Paola Guglielmelli, MD PhD, Niccolò Bartalucci, PhDBSc, Elisa Contini, PhD, Giada Rotunno, PhD, Annalisa Pacilli, PhD, Simone Romagnoli, BSc, Lara Mannelli, MD, Francesco Mannelli, MD, Giacomo Coltro, MD, Alessandro Pancrazzi, PhD, Valentina Ariu, BSci, Sara Fiaccabrino, Roberto Semeraro, Alberto Magi, PhD, Carmela Mannarelli, PhD, Francesca Gesullo, BSci, Chiara Paoli, PhD, Alessandro M. Vannucchi, MD | |
NANOR: A user-friendly R package to analyze and compare nanopore sequencing data | 2019 | Bolognini D.; Bartalucci N.; Mingrino A.; Vannucchi A.M.; Magi A. | |
Calreticulin Ins5 and Del52 mutations impair unfolded protein and oxidative stress responses in K562 cells expressing CALR mutants | 2019 | Salati S.; Genovese E.; Carretta C.; Zini R.; Bartalucci N.; Prudente Z.; Pennucci V.; Ruberti S.; Rossi C.; Rontauroli S.; Enzo E.; Calabresi L.; Balliu M.; Mannarelli C.; Bianchi E.; Guglielmelli P.; Tagliafico E.; Vannucchi A.M.; Manfredini R. | |
Nano-GLADIATOR: real-time detection of copy number alterations from nanopore sequencing data | 2019 | Magi, Alberto; Bolognini, Davide; Bartalucci, Niccoló; Mingrino, Alessandra; Semeraro, Roberto; Giovannini, Luna; Bonifacio, Stefania; Parrini, Daniela; Pelo, Elisabetta; Mannelli, Francesco; Guglielmelli, Paola; Vannucchi, Alessandro Maria | |
Long Reads, Short Time: Feasibility of Prenatal Sample Karyotyping by Nanopore Genome Sequencing | 2019 | Bartalucci, Niccolò; Romagnoli, Simone; Contini, Elisa; Marseglia, Giuseppina; Magi, Alberto; Guglielmelli, Paola; Pelo, Elisabetta; Vannucchi, Alessandro M | |
THIRD GENERATION SEQUENCING OF NORMAL KARYOTYPE ACUTE MYELOID LEUKEMIA: IMPLICATIONS FOR PROGNOSIS | 2019 | Bartalucci, N; Mannelli, F; Contini, E; Romagnoli, S; Gianfaldoni, G; Scappini, B; Pelo, E; Pancani, F; Magi, A; Bosi, A; Guglielmelli, P; Vannucchi, AM | |
Characteristics and clinical correlates of NFE2 mutations in chronic Myeloproliferative neoplasms | 2020 | Guglielmelli P.; Pacilli A.; Coltro G.; Mannelli F.; Mannelli L.; Contini E.; Rotunno G.; Bartalucci N.; Fiaccabrino S.; Sordi B.; Loscocco G.G.; Paoli C.; Vannucchi A.M. | |
Polycythemia vera: the current status of preclinical models and therapeutic targets | 2020 | Bartalucci N.; Guglielmelli P.; Vannucchi A.M. | |
RAS/CBL mutations predict resistance to JAK inhibitors in myelofibrosis and are associated with poor prognostic features | 2020 | Coltro G.; Rotunno G.; Mannelli L.; Mannarelli C.; Fiaccabrino S.; Romagnoli S.; Bartalucci N.; Ravenda E.; Gelli E.; Sant'Antonio E.; Patnaik M.M.; Tefferi A.; Vannucchi A.M.; Guglielmelli P. | |
Activated IL-6 signaling contributes to the pathogenesis of, and is a novel therapeutic target for, CALR-mutated MPNs | 2021 | Balliu M.; Calabresi L.; Bartalucci N.; Romagnoli S.; Maggi L.; Manfredini R.; Lulli M.; Guglielmelli P.; Vannucchi A.M. | |
A blood drop through the pore: nanopore sequencing in hematology | 2021 | Bartalucci N.; Romagnoli S.; Vannucchi A.M. | |
Peripheral nerve resident macrophages and schwann cells mediate cancer-induced pain A C | 2021 | de Logu F.; Marini M.; Landini L.; de Araujo D.S.M.; Bartalucci N.; Trevisan G.; Bruno G.; Marangoni M.; Schmidt B.L.; Bunnett N.W.; Geppetti P.; Nassini R. | |
Philadelphia-negative myeloproliferative neoplasms: From origins to new perspectives | 2021 | Bartalucci, Niccolò; Galluzzi, Lorenzo | |
Nanopore sequencing for the screening of myeloid and lymphoid neoplasms with eosinophilia and rearrangement of PDGFRα, PDGFRβ, FGFR1 or PCM1-JAK2 | 2021 | Romagnoli S.; Bartalucci N.; Gesullo F.; Balliu M.; Bonifacio S.; Fernandez A.G.L.; Mannelli F.; Bolognini D.; Pelo E.; Mecucci C.; Guglielmelli P.; Vannucchi A.M. | |
Immunoblotting-assisted assessment of JAK/STAT and PI3K/Akt/mTOR signaling in myeloproliferative neoplasms CD34+ stem cells | 2022 | Calabresi, Laura; Balliu, Manjola; Bartalucci, Niccolò | |
The Response to Oxidative Damage Correlates with Driver Mutations and Clinical Outcome in Patients with Myelofibrosis | 2022 | Genovese, Elena; Mirabile, Margherita; Rontauroli, Sebastiano; Sartini, Stefano; Fantini, Sebastian; Tavernari, Lara; Maccaferri, Monica; Guglielmelli, Paola; Bianchi, Elisa; Parenti, Sandra; Carretta, Chiara; Mallia, Selene; Castellano, Sara; Colasante, Corrado; Balliu, Manjola; Bartalucci, Niccolò; Palmieri, Raffaele; Ottone, Tiziana; Mora, Barbara; Potenza, Leonardo; Passamonti, Francesco; Voso, Maria Teresa; Luppi, Mario; Vannucchi, Alessandro Maria; Tagliafico, Enrico; Manfredini, Rossella; On Behalf Of The Mynerva MYeloid NEoplasms Research Venture Airc, null |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile